Medicare Enrolled

Dr. Sadaf Jeelani, MD

Endocrinology · Gainesville, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4340 W NEWBERRY RD, Gainesville, FL 32607
3523729414
In practice since 2007 (18 years)
NPI: 1376756981 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jeelani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jeelani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jeelani

Dr. Sadaf Jeelani is an endocrinology specialist in Gainesville, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Jeelani performed 5,343 Medicare services across 1,426 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jeelani received a total of $9,112 from 36 pharmaceutical and/or device companies across 529 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jeelani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 11% volume in FL $9,112 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 100655 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
5,343
Medicare services
Top 11% in FL for endocrinology
1,426
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~297 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,360 $18 $59
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
903 $88 $319
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
261 $78 $274
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
208 $123 $448
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
191 $26 $87
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
118 $9 $24
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
95 $11 $35
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
81 $59 $225
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
51 $46 $144
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
36 $113 $419
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
24 $91 $340
Continuous glucose monitoring, tissue fluid
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin.
15 $44 $145
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,112
Total received (2018-2024)
Avg $1,302/year across 7 years
Top 32% in FL for endocrinology
36
Companies
529
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,999 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$114 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,147
2023
$1,555
2022
$1,341
2021
$956
2020
$1,202
2019
$1,857
2018
$1,054

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$4,049
SANOFI-AVENTIS U.S. LLC
$880
Amgen Inc.
$552
Boehringer Ingelheim Pharmaceuticals, Inc.
$525
Dexcom, Inc.
$434
Abbott Laboratories
$375
Lilly USA, LLC
$290
Insulet Corporation
$265
AstraZeneca Pharmaceuticals LP
$246
Tandem Diabetes Care, Inc.
$143
Medtronic MiniMed, Inc.
$137
Horizon Therapeutics plc
$116
Astellas Pharma US Inc
$114
Radius Health, Inc.
$103
AbbVie, Inc.
$79
Inspire Medical Systems, Inc.
$78
Ascensia Diabetes Care Us Inc.
$75
ABBVIE INC.
$75
Xeris Pharmaceuticals, Inc.
$75
Ipsen Biopharmaceuticals, Inc
$62
AbbVie Inc.
$51
DEXCOM, INC.
$50
Medtronic, Inc.
$43
Novartis Pharmaceuticals Corporation
$41
Shire North American Group Inc
$40
Merck Sharp & Dohme Corporation
$35
Rhythm Pharmaceuticals, Inc.
$33
Antares Pharma, Inc.
$20
GENZYME CORPORATION
$20
Companion Medical, Inc.
$20
Corcept Therapeutics
$18
Kowa Pharmaceuticals America, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$15
IBSA Pharma Inc.
$15
Merck Sharp & Dohme LLC
$14
PFIZER INC.
$12
Top 3 companies account for 60.1% of total payments
Associated products mentioned in payments ›
Androgel · BAQSIMI · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DUPIXENT · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · HUMULIN · INSPIRE · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · Norditropin · Omnipod · Otrexup · Ozempic · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · SYNTHROID · Saxenda · Somatuline Depot · Synthroid · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · Victoza · Wegovy · Xultophy 100/3.6 · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $171 per 100 Medicare services performed
Looking for an endocrinology specialist in Gainesville?
Compare endocrinologists in the Gainesville area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
22
Per 100K population
7.8
County median income
$59,659
Nearest hospital
HCA FLORIDA NORTH FLORIDA HOSPITAL
3.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Jeelani is a clinical cardiology specialist, with above-average Medicare volume (top 11% in FL), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Jeelani experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Jeelani performed 3,360 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jeelani receive payments from pharmaceutical companies?
Yes. Dr. Jeelani received a total of $9,112 from 36 companies across 529 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jeelani's costs compare to other endocrinologists in Gainesville?
Dr. Jeelani's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jeelani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →